Cronos Group (CRON.TO) Saham Harga
Cronos Group Harga
Pendapatan tumbuh 50,8% per tahun selama 10 tahun terakhir menjadi 149,15 Juta. USD. Laba per saham tumbuh 36,5% per tahun selama 9 tahun terakhir. margin bersih Cronos Group saat ini -6,4%, naik dari -613,5% beberapa tahun lalu. Target harga median analis adalah 3,31 USD, di atas harga saat ini sebesar 0,5%. Dari 8 analis, 7 merekomendasikan beli — konsensus keseluruhan Beli.
Harga saham Cronos Group
Akses data ini lewat Eulerpool API
100.000 permintaan/bulan gratis · tanpa kartu
Model bisnis dan analisis saham Cronos Group
Pertanyaan yang sering diajukan tentang saham Cronos Group
The business model of Cronos Group Inc. revolves around the cultivation, production, and distribution of cannabis and cannabis-derived products worldwide. As a leader in the cannabis industry, Cronos Group focuses on developing and building iconic brands, partnering with retail networks, and expanding distribution channels. By prioritizing innovation and research, Cronos Group aims to provide high-quality and differentiated cannabis products to its diverse customer base. With a strategic global presence and a commitment to sustainability, Cronos Group Inc. strives to drive industry growth and shape the future of cannabis.
Cronos Group Inc is primarily active in the cannabis industry.
The main competitors of Cronos Group Inc in the market are Canopy Growth Corporation, Aurora Cannabis Inc, and Tilray Inc.
Cronos Group Inc, a leading Canadian cannabis company, has a rich history and background. Founded in 2013, it quickly established itself as a pioneer in the cannabis industry. The company operates globally and focuses on developing and distributing high-quality cannabis products. Cronos Group Inc has successfully formed partnerships with renowned brands, such as Marlboro-maker Altria Group, enhancing its market position. With a commitment to innovation and sustainability, Cronos prides itself on its diverse portfolio of brands and a strong research and development team. As a market leader, Cronos Group Inc continues to shape the future of the cannabis industry with its dedication to excellence and commitment to delivering shareholder value.
Cronos Group Inc has achieved several significant milestones. The company became the first cannabis producer to be listed on a major stock exchange in 2018, trading on the NASDAQ under the ticker symbol CRON. Additionally, Cronos Group Inc expanded its global presence by entering strategic partnerships and acquisitions in various countries. These include a joint venture in Israel, a supply and distribution agreement in Germany, and a partnership in Australia. Furthermore, the company has focused on research and development initiatives to innovate and develop novel cannabinoid-based products. Cronos Group Inc continues to make strides in the cannabis industry, positioning itself for further growth and success.
Cronos Group Inc is primarily present in Canada and the United States.
Cronos Group Inc represents core values of integrity, innovation, and responsibility. As a leading global cannabinoid company, Cronos Group is committed to providing innovative and high-quality products to its customers. The company's corporate philosophy revolves around transparency, sustainability, and community partnerships. Cronos Group focuses on advancing cannabinoid research, developing industry-leading intellectual property, and driving the growth of the cannabis industry. With a commitment to regulatory compliance and ethical practices, Cronos Group Inc prioritizes the well-being and satisfaction of their stakeholders while promoting the benefits of cannabinoid-based therapies.
Analis saat ini menetapkan target harga rata-rata 3,31 USD untuk saham Cronos Group (median: 3,31 USD), yaitu +0,5 % terhadap harga terbaru. Konsensus didasarkan pada 8 peringkat analis.
9 analis saat ini menilai saham Cronos Group: 8 merekomendasikan beli, 1 tahan, dan 0 jual. Untuk 2026, analis memperkirakan Cronos Group menghasilkan pendapatan 322,06 Juta. USD dan laba per saham 0,18 USD.
Dengan kurs saat ini, saham Cronos Group diperdagangkan pada 2,99 EUR (3,29 USD).
Saham Cronos Group (CRON.TO) tercatat di 5 bursa, termasuk: NASDAQ (CRON), Toronto (CRON.TO), Frankfurt (7CI.F), München (7CI.MU), Düsseldorf (7CI.DU).
The Cronos Group Inc is a Canadian company that operates in the manufacturing and marketing of cannabis products. Cronos' business model is based on vertical integration, allowing the company to complete all steps from cultivation to sales under one roof. One of Cronos' core divisions is cannabis cultivation. The company operates its own cultivation areas in Canada and other countries, equipped with the latest technology and highest standards. Through outdoor and indoor cultivation, Cronos can offer a wide range of cannabis varieties that cater to individual customer needs. Another important aspect of Cronos is the production of cannabis extracts and derivatives. The company utilizes its own cultivation areas and processes the harvested material into high-quality products such as oils, tinctures, capsules, and vapes. The broad portfolio of cannabis derivatives allows Cronos to target different market segments and cover a wide range of applications. In addition to production, Cronos also offers comprehensive consulting services. Experienced consultants and experts are available to assist customers in selecting the right product and individual dosage. This builds trust and customer satisfaction and strengthens the company's image as a responsible cannabis provider. Cronos markets its products through various channels, including its own online shop, retailers, and wholesalers. The company has been particularly successful in international marketing. Cronos collaborates with partners in different countries to position its products in the global market. The company focuses on a high-quality brand strategy and clear positioning as a premium provider. In addition to the mentioned business areas, Cronos also invests in research and development. This is aimed at strengthening the company's position as an innovation leader in the cannabis industry and exploring new applications. One focus is on the medical use of cannabis derivatives, which have shown positive effects in numerous medical conditions. Overall, Cronos' business model is characterized by a clear strategy, professional management, and a broad portfolio of high-quality products. Successful international marketing and positioning as a premium provider contribute significantly to the company's success. Investments in research and development will continue to support Cronos in offering innovative products and expanding its market position.
Pendapatan diperkirakan dari Cronos Group adalah 322,06 Juta. USD. Angka ini didasarkan pada data keuangan terkini dan mencerminkan kinerja bisnis perusahaan.
Laba diperkirakan dari Cronos Group adalah 69,67 Juta. USD. Laba bersih mencerminkan profitabilitas perusahaan setelah mengurangi semua biaya.
Rasio harga-terhadap-pendapatan (PER) Cronos Group saat ini adalah 18,07. PER membandingkan harga saham saat ini dengan laba per saham dan membantu investor menilai valuasi saham Cronos Group.
Rasio harga-terhadap-penjualan (PSR) Cronos Group saat ini adalah 3,91. PSR membandingkan kapitalisasi pasar dengan pendapatan tahunan dan berfungsi sebagai metrik valuasi untuk saham Cronos Group.
Skor Kualitas AlleAktien untuk Cronos Group adalah 3/10.
ISIN dari Cronos Group adalah CA22717L1013. ISIN (International Securities Identification Number) adalah identifikasi unik global untuk sekuritas.
WKN dari Cronos Group adalah A2DMQY. WKN (Wertpapierkennnummer) adalah kode identifikasi sekuritas Jerman enam digit.
Ticker dari Cronos Group adalah CRON.TO. Simbol ticker digunakan untuk memperdagangkan saham Cronos Group di bursa saham.
Saham Cronos Group
Kelompok Peer Cronos Group
Cronos Group Ticker
Cronos Group FIGI
Semua metrik fundamental dan analisis mendalam Cronos Group
Analisis saham kami untuk saham Cronos Group mencakup kalkulasi keuangan penting seperti pendapatan, keuntungan, P/E ratio (P/E), P/S ratio (P/S), EBIT, serta informasi tentang dividen. Selain itu, kami juga mengamati aspek-aspek seperti saham, kapitalisasi pasar, utang, ekuitas, dan kewajiban dari Cronos Group. Jika Anda mencari informasi lebih rinci tentang topik-topik ini, kami menawarkan analisis terperinci di subhalaman kami.